|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 2963058 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15175051.0 |
| Date of filing the European patent application | 2009-11-18 | |
| (97) | Date of publication of the European application | 2016-01-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 116825 P | 2008-11-21 | US | |
| 219903 P | 2009-06-24 | US |
| (72) |
DAVIES, Julian, US
LIU, Ling, US
LU, Jirong, US
VAILLANCOURT, Peter, US
WORTINGER, Mark, US
ZENG, Wei, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | C-MET ANTIBODIES |
| C-MET ANTIBODIES |